1. The Margin Call

The indictment was perfect.

Min Jun-hee had stayed up three nights to make sure of it. The spreadsheets, the trading timestamps, the internal Haesol Pharmaceuticals memoranda—all of it clicked together like the tumblers in a lock. The defendant, Chief Financial Officer Ahn Jae-wook, had sold twenty-three thousand shares of Haesol common stock four days before the company announced that Daesong, its heavily promoted Alzheimer's treatment, had failed to meet Phase III endpoints. The timing was mathematically impossible to dismiss. The profits, parked in a cousin's brokerage account on the offshore exchange in Yonhae, totaled just under two hundred million won.

The case bore the docket number 2025(Go)1052, Financial Instruments and Exchange Act Violation. It would be tried in the Eastern District Court of Goryo, before a three-judge panel. The Tokyo—no, the *Goryo*—financial press had already begun calling it the largest insider trading case of the year.

Jun-hee stood at the floor-to-ceiling window of the prosecutors' office, watching the early-morning fog roll in from the Hangang River. The glass was cold against her forehead. She had been a prosecutor for eight years, and in that time she had learned one thing above all others: a crime, any crime, was only as legible as the law that defined it. The law was a lens. If the lens was ground correctly, the offense came into sharp focus. If the lens was warped, or outdated, or deliberately blurred, even the most monstrous act could look like a clerical error.

She turned back to her desk. The office was empty except for her; the other prosecutors in the Financial Crimes Division would not arrive for another two hours. On her computer screen, the Securities and Exchange Surveillance Commission's referral letter glowed faintly. The SESC had flagged Ahn's trades three months ago, in October 2024. They had traced the account, interviewed the cousin, and compiled a forensic timeline that even a first-year law student could follow. The case had been handed to her division in January. Jun-hee had filed the indictment on the third of March.

It was now March tenth. The arraignment was scheduled for nine o'clock.

She reviewed her notes one final time. The defendant was forty-seven years old, a graduate of Goryo National University's business school, married with two daughters. No prior criminal record. No history of securities violations. He had been CFO of Haesol for six years, during which time the company's market capitalization had quadrupled, largely on the promise of Daesong. The drug was supposed to be a breakthrough—a monoclonal antibody that cleared amyloid plaques from the brain with unprecedented efficiency. Early trials had shown remarkable results. The medical journals had published glowing editorials. The Ministry of Health had fast-tracked its approval review.

And then, on November fifteenth of the previous year, the Phase III data had come back. The drug worked no better than placebo. Worse, a small subset of elderly patients—approximately three percent of the trial population—had developed fulminant hepatic necrosis, a catastrophic liver failure that killed within days. The deaths had been recorded in the clinical database but not publicly disclosed. Ahn, according to the prosecution's theory, had seen the data two weeks before the public announcement and had acted on it.

The motive was clear. The evidence was clear. The law was clear.

Jun-hee gathered her files and walked to the elevator.

The Eastern District Court was a concrete monolith built in the 1980s, its façade streaked with decades of rain stains. Jun-hee had always found the building oppressive, but today she felt something else—a strange lightness, the sense that she was moving through a world that had temporarily aligned itself with her intentions.

The courtroom was half-empty. A few reporters sat in the gallery, their notebooks open. The defendant's wife was in the second row, her face pale and expressionless. Jun-hee took her place at the prosecution table and waited.

Ahn Jae-wook was led in by two court officers. He was a thin man with graying hair and wire-rimmed glasses, and he moved with the shuffling gait of someone who had not slept in weeks. His eyes scanned the room and settled on his wife for a moment before dropping to the floor.

The presiding judge, a woman named Park Eun-kyung, entered and called the court to order. The charges were read. The defense counsel, a prominent white-collar attorney named Nam Ki-tae, entered a plea of not guilty.

Jun-hee was not surprised. She had expected a not-guilty plea; it was standard strategy in financial cases, a way to buy time for plea negotiations. What she had not expected was the defendant's demeanor. Ahn did not look defiant or calculating. He looked hollowed out, like a man who had already lost something irreplaceable.

The judge set a trial date for April and adjourned the hearing. Jun-hee gathered her files and was halfway to the door when a court clerk approached her.

"Prosecutor Min, the defendant has requested a meeting."

Jun-hee frowned. "His attorney approved this?"

"The request came through defense counsel. They want to discuss a possible cooperation agreement."

This was more surprising. Cooperation agreements were rare in financial cases; most defendants fought to the end, hoping to exploit procedural loopholes or sympathetic judges. Ahn's willingness to talk suggested either genuine remorse or a strategic calculation that Jun-hee did not yet understand.

She agreed to the meeting. It was scheduled for the following afternoon, in an interview room at the detention center.

That night, Jun-hee returned to her apartment in the Hannam district and cooked a simple meal of rice and fermented vegetables. She ate alone at her small kitchen table, the television murmuring in the background. The news was covering the indictment, showing footage of Haesol's headquarters—a gleaming glass tower in the Goryo International Finance Center—and stock footage of elderly patients in nursing homes, their faces blurred for privacy.

One of the reporters mentioned that Haesol's stock had fallen forty percent since the November announcement. Thousands of retail investors had lost their savings. Pension funds had written down billions of won in losses. The human cost, the reporter said, was incalculable.

Jun-hee turned off the television and sat in the dark. The human cost. She had heard that phrase a hundred times in her career, and each time it felt more hollow than the last. The law did not measure human cost. It measured statutes, precedents, and penalties. It measured what could be proven, not what could be felt.

She thought about the three percent. Three percent of the trial population. How many patients was that? She did not know. The clinical data was sealed pending the Ministry of Health's investigation, and her case was limited to the financial violation. The deaths were not part of her indictment. They were, strictly speaking, none of her business.

She went to bed early, but sleep did not come.

The next afternoon, Jun-hee arrived at the detention center at two o'clock. The interview room was small and windowless, with a metal table bolted to the floor and two plastic chairs. Ahn Jae-wook was already seated when she entered, his hands cuffed loosely in front of him. His attorney, Nam Ki-tae, sat beside him.

"Thank you for coming, Prosecutor Min," Nam said. He was a smooth-faced man in his fifties, impeccably dressed, with the kind of practiced calm that came from decades of representing wealthy clients. "My client would like to make a statement."

Jun-hee sat down and placed a digital recorder on the table. "The interview is being recorded. Your client understands his rights?"

"He does."

Jun-hee looked at Ahn. "Mr. Ahn, you requested this meeting. What would you like to say?"

Ahn did not look at her. His eyes were fixed on the table, as if reading something written in the scratches on its surface. When he spoke, his voice was barely above a whisper.

"I sold the shares," he said. "I knew the data was coming. I knew it would destroy the stock. I sold everything I could."

Jun-hee waited. The confession was not surprising; the evidence was overwhelming, and Ahn's attorney would have advised him that cooperation was his only chance at a reduced sentence.

"Who else knew?" Jun-hee asked.

"About the trading? No one. Only my cousin, and he did what I told him."

"I mean about the data. The Phase III results. Who else had access before the public announcement?"

Ahn's hands trembled slightly. "The clinical team. The regulatory affairs department. The board of directors. Everyone who needed to know."

"And did anyone else trade on the information?"

"I don't know. I didn't ask."

Jun-hee made a note. The SESC had not found evidence of other traders, but the possibility remained open. "Is there anything else you want to tell me, Mr. Ahn? Anything that might be relevant to the investigation?"

For a long moment, Ahn said nothing. His attorney leaned over and whispered something in his ear. Ahn shook his head slightly.

Then he looked up at Jun-hee, and for the first time she saw something in his eyes that was not exhaustion or shame. It was fear. Pure, unadulterated fear.

"Prosecutor Min," he said, "have you ever heard of a place called Sacred Garden?"

The name meant nothing to her. She wrote it down. "What is Sacred Garden?"

"It's a nursing home. In the mountains, near the Nambuk prefecture border. Haesol owns it. Or owns the company that owns it. I'm not sure of the exact structure."

"Why are you telling me this?"

Ahn's hands were shaking visibly now. His attorney put a restraining hand on his arm, but Ahn pulled away.

"Because the three percent," Ahn said. "The three percent who died in the trials. Those weren't the only ones."

Jun-hee's pen stopped moving. "What do you mean?"

"The drug had side effects. Bad ones. The company knew about them years ago, but they buried the data. They kept testing anyway. And when the Phase III results came back with the liver toxicity signal, they needed to... they needed to make sure the problem wasn't wider than the trial population."

"Make sure how?"

Ahn's voice dropped to a whisper. "Sacred Garden. They tested the drug on the residents there. Elderly patients, mostly dementia cases. People without families. People no one would miss."

The room seemed to contract around Jun-hee. She became aware of the fluorescent light buzzing overhead, the faint smell of disinfectant, the distant clang of a metal door.

"How many?" she asked.

"I don't know."

"How long has this been going on?"

"Years. Maybe longer. I'm not in the clinical division. I only heard things. Rumors. But after the November data came back, there was a meeting. The CEO, the chief scientific officer, a few others. They talked about Sacred Garden. They talked about... cleaning up the data."

"Cleaning up how?"

Ahn looked at her with the hollow eyes of a man who had already crossed a line he could not uncross. "You would have to see it to understand. And even then, you might not. The law doesn't see things like this, Prosecutor Min. The law looks at spreadsheets and trading timestamps. It doesn't look at old people dying in the mountains."

Jun-hee felt a coldness spreading through her chest. She had become a prosecutor because she believed in the law's power to see, to name, to punish. She had believed that the lens could be ground sharp enough to bring any crime into focus.

But Ahn was telling her something else. He was telling her that the lens was not just blurred; it was pointed in the wrong direction entirely.

"Why are you telling me this now?" she asked.

Ahn's attorney answered for him. "My client is prepared to provide full cooperation regarding the insider trading charges. In exchange, he is requesting a reduced sentence. The information about Sacred Garden is being offered as a demonstration of good faith."

Good faith. Jun-hee almost laughed. Ahn was trying to trade one crime for another, offering up a darker secret in exchange for leniency on his own.

But that did not make the secret any less real.

She ended the interview and walked out of the detention center into the gray afternoon light. The city spread out before her, a grid of concrete and glass and neon. Somewhere in the mountains to the north, there was a nursing home called Sacred Garden. Somewhere in that nursing home, there were bodies buried in the data.

She pulled out her phone and called her supervisor, Chief Prosecutor Kang Dong-won.

"Sir, I need to request an expansion of the investigation."

The line was silent for a moment. "On what grounds?"

"Evidence of possible homicide. Or manslaughter. I'm not sure yet."

More silence. Then: "Come to my office. Now."

Jun-hee hung up and began walking toward the prosecutors' building. The fog from the river had lifted, but the sky remained overcast, the clouds pressing down on the city like a lid. She thought about what Ahn had said. *The law doesn't see things like this.* It was not a confession of helplessness. It was a confession of design. Someone, somewhere, had built a crime that fit perfectly into the law's blind spots. Someone had understood that the system could only prosecute what it could recognize, and had designed their horror accordingly.

She did not yet know the name of the person who had designed it. But she knew, with a certainty that felt almost physical, that she would find out.

And when she did, the lens would have to be remade.

The elevator doors opened. She stepped inside and pressed the button for the eighth floor. As the car rose, she caught her reflection in the polished steel doors—a woman of thirty-four, dark hair pulled back, eyes shadowed with exhaustion. She looked like a prosecutor. She looked like someone who believed in the law.

She was not sure, anymore, whether that was a strength or a weakness.

The doors opened. She walked into the corridor and toward her supervisor's office, carrying the file that contained everything she knew and nothing that mattered.

Behind her, unseen, the city continued its indifferent hum. In the mountains to the north, the residents of Sacred Garden were eating their evening meal, taking their evening medications, going to sleep in beds that had been bought and paid for by a pharmaceutical company that needed their deaths. The law did not see them. The law was looking somewhere else entirely.

But Min Jun-hee was looking now. And once she started looking, she would not stop.

Even if stopping would have been the wiser choice.

Even if looking would cost her everything she had built.

She knocked on the door.

"Come in," said the voice from inside.

She turned the handle and stepped through, into a room where the rest of her life was waiting to begin.